The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Cancer Respiratory Biopsy Market Research Report 2025
Synopsis
The global market for Cancer Respiratory Biopsy was valued at US$ 350 million in the year 2024 and is projected to reach a revised size of US$ 1251 million by 2031, growing at a CAGR of 20.0% during the forecast period.
Cancer respiratory biopsy is a non-invasive diagnostic technique that detects cancer by analyzing volatile organic compounds (VOCs) or other biomarkers in a patient's exhaled breath. These biomarkers may be generated by tumor metabolic activity and excreted through respiration. Compared to traditional tissue biopsies such as puncture or bronchoscopy biopsy, respiratory biopsy has advantages such as non invasiveness, convenience, and strong reproducibility, especially suitable for early screening and monitoring of respiratory diseases such as lung cancer. The detection methods usually involve techniques such as mass spectrometry, gas chromatography-mass spectrometry (GC-MS), sensors, etc.
In recent years, the global cancer respiratory biopsy market has maintained a growth trend. The increase in incidence rate of cancer (especially lung cancer), minimally invasive trend, technological progress and policy support are the main driving factors. Lung cancer is one of the cancers with the highest incidence in the world and China, which has promoted the demand for early non-invasive detection technology. Compared to traditional cancer biopsies, respiratory biopsies are safer and more widely accepted by patients. AI assisted analysis, improved sensor sensitivity, and multimodal image fusion (such as combining CT or MRI) have enhanced the accuracy of respiratory biopsy. In addition, early screening for cancer has been included in some countries' medical insurance, reducing the burden on patients and promoting the popularization of technology. The main participants include international companies such as Owlstone Medical, Breath Diagnostics, and Menssana Research, as well as domestic companies such as BREAX Biotech and ChromX Health. The main challenges facing the market include technological maturity, insufficient standardization, cost and promotion issues. The sensitivity and specificity of respiratory biopsy still need to be optimized and have not yet become the clinical gold standard. And there are significant differences in the biomarkers of different detection methods, lacking a unified standard. High research and development costs and equipment investment may limit the popularization of primary healthcare institutions. In the future, intelligence, portable devices, and multi cancer detection will be the main development trends in the industry. AI and machine learning will be used for real-time analysis of respiratory data to improve diagnostic efficiency. The development of miniaturized and wireless detection equipment will facilitate the use of community hospitals. In addition to lung cancer, companies will also expand their research into respiratory biomarkers for other cancers such as gastric cancer and colorectal cancer.
This report aims to provide a comprehensive presentation of the global market for Cancer Respiratory Biopsy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Respiratory Biopsy.
The Cancer Respiratory Biopsy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cancer Respiratory Biopsy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cancer Respiratory Biopsy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Owlstone Medical
Breath Diagnostics
Menssana Research
Sensigent
Alpha Szenszor
NanoScent
Spira Innovation
Syft Technologies
Breathe Biomedical
Vocxi Health
BREAX Biotech
ChromX Health
Sunvou Medical
MaiAoTech
Hanon Instruments
WIM Spirare
Segment by Type
Mass Spectrometry Technology Based Respiratory Detection
Gas Chromatography-Mass Spectrometry Based Respiratory Detection
Sensor Based Respiratory Detection
Segment by Application
Lung Cancer Early Screening
Colorectal Cancer Detection
Liver Cancer Detection
Esophageal Cancer Detection
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cancer Respiratory Biopsy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global market for Cancer Respiratory Biopsy was valued at US$ 350 million in the year 2024 and is projected to reach a revised size of US$ 1251 million by 2031, growing at a CAGR of 20.0% during the forecast period.
Cancer respiratory biopsy is a non-invasive diagnostic technique that detects cancer by analyzing volatile organic compounds (VOCs) or other biomarkers in a patient's exhaled breath. These biomarkers may be generated by tumor metabolic activity and excreted through respiration. Compared to traditional tissue biopsies such as puncture or bronchoscopy biopsy, respiratory biopsy has advantages such as non invasiveness, convenience, and strong reproducibility, especially suitable for early screening and monitoring of respiratory diseases such as lung cancer. The detection methods usually involve techniques such as mass spectrometry, gas chromatography-mass spectrometry (GC-MS), sensors, etc.
In recent years, the global cancer respiratory biopsy market has maintained a growth trend. The increase in incidence rate of cancer (especially lung cancer), minimally invasive trend, technological progress and policy support are the main driving factors. Lung cancer is one of the cancers with the highest incidence in the world and China, which has promoted the demand for early non-invasive detection technology. Compared to traditional cancer biopsies, respiratory biopsies are safer and more widely accepted by patients. AI assisted analysis, improved sensor sensitivity, and multimodal image fusion (such as combining CT or MRI) have enhanced the accuracy of respiratory biopsy. In addition, early screening for cancer has been included in some countries' medical insurance, reducing the burden on patients and promoting the popularization of technology. The main participants include international companies such as Owlstone Medical, Breath Diagnostics, and Menssana Research, as well as domestic companies such as BREAX Biotech and ChromX Health. The main challenges facing the market include technological maturity, insufficient standardization, cost and promotion issues. The sensitivity and specificity of respiratory biopsy still need to be optimized and have not yet become the clinical gold standard. And there are significant differences in the biomarkers of different detection methods, lacking a unified standard. High research and development costs and equipment investment may limit the popularization of primary healthcare institutions. In the future, intelligence, portable devices, and multi cancer detection will be the main development trends in the industry. AI and machine learning will be used for real-time analysis of respiratory data to improve diagnostic efficiency. The development of miniaturized and wireless detection equipment will facilitate the use of community hospitals. In addition to lung cancer, companies will also expand their research into respiratory biomarkers for other cancers such as gastric cancer and colorectal cancer.
This report aims to provide a comprehensive presentation of the global market for Cancer Respiratory Biopsy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Respiratory Biopsy.
The Cancer Respiratory Biopsy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cancer Respiratory Biopsy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cancer Respiratory Biopsy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Owlstone Medical
Breath Diagnostics
Menssana Research
Sensigent
Alpha Szenszor
NanoScent
Spira Innovation
Syft Technologies
Breathe Biomedical
Vocxi Health
BREAX Biotech
ChromX Health
Sunvou Medical
MaiAoTech
Hanon Instruments
WIM Spirare
Segment by Type
Mass Spectrometry Technology Based Respiratory Detection
Gas Chromatography-Mass Spectrometry Based Respiratory Detection
Sensor Based Respiratory Detection
Segment by Application
Lung Cancer Early Screening
Colorectal Cancer Detection
Liver Cancer Detection
Esophageal Cancer Detection
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cancer Respiratory Biopsy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Respiratory Biopsy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Mass Spectrometry Technology Based Respiratory Detection
1.2.3 Gas Chromatography-Mass Spectrometry Based Respiratory Detection
1.2.4 Sensor Based Respiratory Detection
1.3 Market by Application
1.3.1 Global Cancer Respiratory Biopsy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Lung Cancer Early Screening
1.3.3 Colorectal Cancer Detection
1.3.4 Liver Cancer Detection
1.3.5 Esophageal Cancer Detection
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cancer Respiratory Biopsy Market Perspective (2020-2031)
2.2 Global Cancer Respiratory Biopsy Growth Trends by Region
2.2.1 Global Cancer Respiratory Biopsy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Cancer Respiratory Biopsy Historic Market Size by Region (2020-2025)
2.2.3 Cancer Respiratory Biopsy Forecasted Market Size by Region (2026-2031)
2.3 Cancer Respiratory Biopsy Market Dynamics
2.3.1 Cancer Respiratory Biopsy Industry Trends
2.3.2 Cancer Respiratory Biopsy Market Drivers
2.3.3 Cancer Respiratory Biopsy Market Challenges
2.3.4 Cancer Respiratory Biopsy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Respiratory Biopsy Players by Revenue
3.1.1 Global Top Cancer Respiratory Biopsy Players by Revenue (2020-2025)
3.1.2 Global Cancer Respiratory Biopsy Revenue Market Share by Players (2020-2025)
3.2 Global Top Cancer Respiratory Biopsy Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cancer Respiratory Biopsy Revenue
3.4 Global Cancer Respiratory Biopsy Market Concentration Ratio
3.4.1 Global Cancer Respiratory Biopsy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Respiratory Biopsy Revenue in 2024
3.5 Global Key Players of Cancer Respiratory Biopsy Head office and Area Served
3.6 Global Key Players of Cancer Respiratory Biopsy, Product and Application
3.7 Global Key Players of Cancer Respiratory Biopsy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Respiratory Biopsy Breakdown Data by Type
4.1 Global Cancer Respiratory Biopsy Historic Market Size by Type (2020-2025)
4.2 Global Cancer Respiratory Biopsy Forecasted Market Size by Type (2026-2031)
5 Cancer Respiratory Biopsy Breakdown Data by Application
5.1 Global Cancer Respiratory Biopsy Historic Market Size by Application (2020-2025)
5.2 Global Cancer Respiratory Biopsy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Cancer Respiratory Biopsy Market Size (2020-2031)
6.2 North America Cancer Respiratory Biopsy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Cancer Respiratory Biopsy Market Size by Country (2020-2025)
6.4 North America Cancer Respiratory Biopsy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cancer Respiratory Biopsy Market Size (2020-2031)
7.2 Europe Cancer Respiratory Biopsy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Cancer Respiratory Biopsy Market Size by Country (2020-2025)
7.4 Europe Cancer Respiratory Biopsy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cancer Respiratory Biopsy Market Size (2020-2031)
8.2 Asia-Pacific Cancer Respiratory Biopsy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Cancer Respiratory Biopsy Market Size by Region (2020-2025)
8.4 Asia-Pacific Cancer Respiratory Biopsy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cancer Respiratory Biopsy Market Size (2020-2031)
9.2 Latin America Cancer Respiratory Biopsy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Cancer Respiratory Biopsy Market Size by Country (2020-2025)
9.4 Latin America Cancer Respiratory Biopsy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Respiratory Biopsy Market Size (2020-2031)
10.2 Middle East & Africa Cancer Respiratory Biopsy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Cancer Respiratory Biopsy Market Size by Country (2020-2025)
10.4 Middle East & Africa Cancer Respiratory Biopsy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Owlstone Medical
11.1.1 Owlstone Medical Company Details
11.1.2 Owlstone Medical Business Overview
11.1.3 Owlstone Medical Cancer Respiratory Biopsy Introduction
11.1.4 Owlstone Medical Revenue in Cancer Respiratory Biopsy Business (2020-2025)
11.1.5 Owlstone Medical Recent Development
11.2 Breath Diagnostics
11.2.1 Breath Diagnostics Company Details
11.2.2 Breath Diagnostics Business Overview
11.2.3 Breath Diagnostics Cancer Respiratory Biopsy Introduction
11.2.4 Breath Diagnostics Revenue in Cancer Respiratory Biopsy Business (2020-2025)
11.2.5 Breath Diagnostics Recent Development
11.3 Menssana Research
11.3.1 Menssana Research Company Details
11.3.2 Menssana Research Business Overview
11.3.3 Menssana Research Cancer Respiratory Biopsy Introduction
11.3.4 Menssana Research Revenue in Cancer Respiratory Biopsy Business (2020-2025)
11.3.5 Menssana Research Recent Development
11.4 Sensigent
11.4.1 Sensigent Company Details
11.4.2 Sensigent Business Overview
11.4.3 Sensigent Cancer Respiratory Biopsy Introduction
11.4.4 Sensigent Revenue in Cancer Respiratory Biopsy Business (2020-2025)
11.4.5 Sensigent Recent Development
11.5 Alpha Szenszor
11.5.1 Alpha Szenszor Company Details
11.5.2 Alpha Szenszor Business Overview
11.5.3 Alpha Szenszor Cancer Respiratory Biopsy Introduction
11.5.4 Alpha Szenszor Revenue in Cancer Respiratory Biopsy Business (2020-2025)
11.5.5 Alpha Szenszor Recent Development
11.6 NanoScent
11.6.1 NanoScent Company Details
11.6.2 NanoScent Business Overview
11.6.3 NanoScent Cancer Respiratory Biopsy Introduction
11.6.4 NanoScent Revenue in Cancer Respiratory Biopsy Business (2020-2025)
11.6.5 NanoScent Recent Development
11.7 Spira Innovation
11.7.1 Spira Innovation Company Details
11.7.2 Spira Innovation Business Overview
11.7.3 Spira Innovation Cancer Respiratory Biopsy Introduction
11.7.4 Spira Innovation Revenue in Cancer Respiratory Biopsy Business (2020-2025)
11.7.5 Spira Innovation Recent Development
11.8 Syft Technologies
11.8.1 Syft Technologies Company Details
11.8.2 Syft Technologies Business Overview
11.8.3 Syft Technologies Cancer Respiratory Biopsy Introduction
11.8.4 Syft Technologies Revenue in Cancer Respiratory Biopsy Business (2020-2025)
11.8.5 Syft Technologies Recent Development
11.9 Breathe Biomedical
11.9.1 Breathe Biomedical Company Details
11.9.2 Breathe Biomedical Business Overview
11.9.3 Breathe Biomedical Cancer Respiratory Biopsy Introduction
11.9.4 Breathe Biomedical Revenue in Cancer Respiratory Biopsy Business (2020-2025)
11.9.5 Breathe Biomedical Recent Development
11.10 Vocxi Health
11.10.1 Vocxi Health Company Details
11.10.2 Vocxi Health Business Overview
11.10.3 Vocxi Health Cancer Respiratory Biopsy Introduction
11.10.4 Vocxi Health Revenue in Cancer Respiratory Biopsy Business (2020-2025)
11.10.5 Vocxi Health Recent Development
11.11 BREAX Biotech
11.11.1 BREAX Biotech Company Details
11.11.2 BREAX Biotech Business Overview
11.11.3 BREAX Biotech Cancer Respiratory Biopsy Introduction
11.11.4 BREAX Biotech Revenue in Cancer Respiratory Biopsy Business (2020-2025)
11.11.5 BREAX Biotech Recent Development
11.12 ChromX Health
11.12.1 ChromX Health Company Details
11.12.2 ChromX Health Business Overview
11.12.3 ChromX Health Cancer Respiratory Biopsy Introduction
11.12.4 ChromX Health Revenue in Cancer Respiratory Biopsy Business (2020-2025)
11.12.5 ChromX Health Recent Development
11.13 Sunvou Medical
11.13.1 Sunvou Medical Company Details
11.13.2 Sunvou Medical Business Overview
11.13.3 Sunvou Medical Cancer Respiratory Biopsy Introduction
11.13.4 Sunvou Medical Revenue in Cancer Respiratory Biopsy Business (2020-2025)
11.13.5 Sunvou Medical Recent Development
11.14 MaiAoTech
11.14.1 MaiAoTech Company Details
11.14.2 MaiAoTech Business Overview
11.14.3 MaiAoTech Cancer Respiratory Biopsy Introduction
11.14.4 MaiAoTech Revenue in Cancer Respiratory Biopsy Business (2020-2025)
11.14.5 MaiAoTech Recent Development
11.15 Hanon Instruments
11.15.1 Hanon Instruments Company Details
11.15.2 Hanon Instruments Business Overview
11.15.3 Hanon Instruments Cancer Respiratory Biopsy Introduction
11.15.4 Hanon Instruments Revenue in Cancer Respiratory Biopsy Business (2020-2025)
11.15.5 Hanon Instruments Recent Development
11.16 WIM Spirare
11.16.1 WIM Spirare Company Details
11.16.2 WIM Spirare Business Overview
11.16.3 WIM Spirare Cancer Respiratory Biopsy Introduction
11.16.4 WIM Spirare Revenue in Cancer Respiratory Biopsy Business (2020-2025)
11.16.5 WIM Spirare Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of TablesList of Tables
Table 1. Global Cancer Respiratory Biopsy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Mass Spectrometry Technology Based Respiratory Detection
Table 3. Key Players of Gas Chromatography-Mass Spectrometry Based Respiratory Detection
Table 4. Key Players of Sensor Based Respiratory Detection
Table 5. Global Cancer Respiratory Biopsy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Cancer Respiratory Biopsy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Cancer Respiratory Biopsy Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Cancer Respiratory Biopsy Market Share by Region (2020-2025)
Table 9. Global Cancer Respiratory Biopsy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Cancer Respiratory Biopsy Market Share by Region (2026-2031)
Table 11. Cancer Respiratory Biopsy Market Trends
Table 12. Cancer Respiratory Biopsy Market Drivers
Table 13. Cancer Respiratory Biopsy Market Challenges
Table 14. Cancer Respiratory Biopsy Market Restraints
Table 15. Global Cancer Respiratory Biopsy Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Cancer Respiratory Biopsy Market Share by Players (2020-2025)
Table 17. Global Top Cancer Respiratory Biopsy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Respiratory Biopsy as of 2024)
Table 18. Ranking of Global Top Cancer Respiratory Biopsy Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Cancer Respiratory Biopsy Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Cancer Respiratory Biopsy, Headquarters and Area Served
Table 21. Global Key Players of Cancer Respiratory Biopsy, Product and Application
Table 22. Global Key Players of Cancer Respiratory Biopsy, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Cancer Respiratory Biopsy Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Cancer Respiratory Biopsy Revenue Market Share by Type (2020-2025)
Table 26. Global Cancer Respiratory Biopsy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Cancer Respiratory Biopsy Revenue Market Share by Type (2026-2031)
Table 28. Global Cancer Respiratory Biopsy Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Cancer Respiratory Biopsy Revenue Market Share by Application (2020-2025)
Table 30. Global Cancer Respiratory Biopsy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Cancer Respiratory Biopsy Revenue Market Share by Application (2026-2031)
Table 32. North America Cancer Respiratory Biopsy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Cancer Respiratory Biopsy Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Cancer Respiratory Biopsy Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Cancer Respiratory Biopsy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Cancer Respiratory Biopsy Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Cancer Respiratory Biopsy Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Cancer Respiratory Biopsy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Cancer Respiratory Biopsy Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Cancer Respiratory Biopsy Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Cancer Respiratory Biopsy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Cancer Respiratory Biopsy Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Cancer Respiratory Biopsy Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Cancer Respiratory Biopsy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Cancer Respiratory Biopsy Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Cancer Respiratory Biopsy Market Size by Country (2026-2031) & (US$ Million)
Table 47. Owlstone Medical Company Details
Table 48. Owlstone Medical Business Overview
Table 49. Owlstone Medical Cancer Respiratory Biopsy Product
Table 50. Owlstone Medical Revenue in Cancer Respiratory Biopsy Business (2020-2025) & (US$ Million)
Table 51. Owlstone Medical Recent Development
Table 52. Breath Diagnostics Company Details
Table 53. Breath Diagnostics Business Overview
Table 54. Breath Diagnostics Cancer Respiratory Biopsy Product
Table 55. Breath Diagnostics Revenue in Cancer Respiratory Biopsy Business (2020-2025) & (US$ Million)
Table 56. Breath Diagnostics Recent Development
Table 57. Menssana Research Company Details
Table 58. Menssana Research Business Overview
Table 59. Menssana Research Cancer Respiratory Biopsy Product
Table 60. Menssana Research Revenue in Cancer Respiratory Biopsy Business (2020-2025) & (US$ Million)
Table 61. Menssana Research Recent Development
Table 62. Sensigent Company Details
Table 63. Sensigent Business Overview
Table 64. Sensigent Cancer Respiratory Biopsy Product
Table 65. Sensigent Revenue in Cancer Respiratory Biopsy Business (2020-2025) & (US$ Million)
Table 66. Sensigent Recent Development
Table 67. Alpha Szenszor Company Details
Table 68. Alpha Szenszor Business Overview
Table 69. Alpha Szenszor Cancer Respiratory Biopsy Product
Table 70. Alpha Szenszor Revenue in Cancer Respiratory Biopsy Business (2020-2025) & (US$ Million)
Table 71. Alpha Szenszor Recent Development
Table 72. NanoScent Company Details
Table 73. NanoScent Business Overview
Table 74. NanoScent Cancer Respiratory Biopsy Product
Table 75. NanoScent Revenue in Cancer Respiratory Biopsy Business (2020-2025) & (US$ Million)
Table 76. NanoScent Recent Development
Table 77. Spira Innovation Company Details
Table 78. Spira Innovation Business Overview
Table 79. Spira Innovation Cancer Respiratory Biopsy Product
Table 80. Spira Innovation Revenue in Cancer Respiratory Biopsy Business (2020-2025) & (US$ Million)
Table 81. Spira Innovation Recent Development
Table 82. Syft Technologies Company Details
Table 83. Syft Technologies Business Overview
Table 84. Syft Technologies Cancer Respiratory Biopsy Product
Table 85. Syft Technologies Revenue in Cancer Respiratory Biopsy Business (2020-2025) & (US$ Million)
Table 86. Syft Technologies Recent Development
Table 87. Breathe Biomedical Company Details
Table 88. Breathe Biomedical Business Overview
Table 89. Breathe Biomedical Cancer Respiratory Biopsy Product
Table 90. Breathe Biomedical Revenue in Cancer Respiratory Biopsy Business (2020-2025) & (US$ Million)
Table 91. Breathe Biomedical Recent Development
Table 92. Vocxi Health Company Details
Table 93. Vocxi Health Business Overview
Table 94. Vocxi Health Cancer Respiratory Biopsy Product
Table 95. Vocxi Health Revenue in Cancer Respiratory Biopsy Business (2020-2025) & (US$ Million)
Table 96. Vocxi Health Recent Development
Table 97. BREAX Biotech Company Details
Table 98. BREAX Biotech Business Overview
Table 99. BREAX Biotech Cancer Respiratory Biopsy Product
Table 100. BREAX Biotech Revenue in Cancer Respiratory Biopsy Business (2020-2025) & (US$ Million)
Table 101. BREAX Biotech Recent Development
Table 102. ChromX Health Company Details
Table 103. ChromX Health Business Overview
Table 104. ChromX Health Cancer Respiratory Biopsy Product
Table 105. ChromX Health Revenue in Cancer Respiratory Biopsy Business (2020-2025) & (US$ Million)
Table 106. ChromX Health Recent Development
Table 107. Sunvou Medical Company Details
Table 108. Sunvou Medical Business Overview
Table 109. Sunvou Medical Cancer Respiratory Biopsy Product
Table 110. Sunvou Medical Revenue in Cancer Respiratory Biopsy Business (2020-2025) & (US$ Million)
Table 111. Sunvou Medical Recent Development
Table 112. MaiAoTech Company Details
Table 113. MaiAoTech Business Overview
Table 114. MaiAoTech Cancer Respiratory Biopsy Product
Table 115. MaiAoTech Revenue in Cancer Respiratory Biopsy Business (2020-2025) & (US$ Million)
Table 116. MaiAoTech Recent Development
Table 117. Hanon Instruments Company Details
Table 118. Hanon Instruments Business Overview
Table 119. Hanon Instruments Cancer Respiratory Biopsy Product
Table 120. Hanon Instruments Revenue in Cancer Respiratory Biopsy Business (2020-2025) & (US$ Million)
Table 121. Hanon Instruments Recent Development
Table 122. WIM Spirare Company Details
Table 123. WIM Spirare Business Overview
Table 124. WIM Spirare Cancer Respiratory Biopsy Product
Table 125. WIM Spirare Revenue in Cancer Respiratory Biopsy Business (2020-2025) & (US$ Million)
Table 126. WIM Spirare Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
Table 130. Authors List of This Report
List of Figures
Figure 1. Cancer Respiratory Biopsy Picture
Figure 2. Global Cancer Respiratory Biopsy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Cancer Respiratory Biopsy Market Share by Type: 2024 VS 2031
Figure 4. Mass Spectrometry Technology Based Respiratory Detection Features
Figure 5. Gas Chromatography-Mass Spectrometry Based Respiratory Detection Features
Figure 6. Sensor Based Respiratory Detection Features
Figure 7. Global Cancer Respiratory Biopsy Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Cancer Respiratory Biopsy Market Share by Application: 2024 VS 2031
Figure 9. Lung Cancer Early Screening Case Studies
Figure 10. Colorectal Cancer Detection Case Studies
Figure 11. Liver Cancer Detection Case Studies
Figure 12. Esophageal Cancer Detection Case Studies
Figure 13. Others Case Studies
Figure 14. Cancer Respiratory Biopsy Report Years Considered
Figure 15. Global Cancer Respiratory Biopsy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Cancer Respiratory Biopsy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Cancer Respiratory Biopsy Market Share by Region: 2024 VS 2031
Figure 18. Global Cancer Respiratory Biopsy Market Share by Players in 2024
Figure 19. Global Cancer Respiratory Biopsy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 20. The Top 10 and 5 Players Market Share by Cancer Respiratory Biopsy Revenue in 2024
Figure 21. North America Cancer Respiratory Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Cancer Respiratory Biopsy Market Share by Country (2020-2031)
Figure 23. United States Cancer Respiratory Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Cancer Respiratory Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Cancer Respiratory Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Cancer Respiratory Biopsy Market Share by Country (2020-2031)
Figure 27. Germany Cancer Respiratory Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Cancer Respiratory Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Cancer Respiratory Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Cancer Respiratory Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Cancer Respiratory Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Cancer Respiratory Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Cancer Respiratory Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Cancer Respiratory Biopsy Market Share by Region (2020-2031)
Figure 35. China Cancer Respiratory Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Cancer Respiratory Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Cancer Respiratory Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Cancer Respiratory Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Cancer Respiratory Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Cancer Respiratory Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Cancer Respiratory Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Cancer Respiratory Biopsy Market Share by Country (2020-2031)
Figure 43. Mexico Cancer Respiratory Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Cancer Respiratory Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Cancer Respiratory Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Cancer Respiratory Biopsy Market Share by Country (2020-2031)
Figure 47. Turkey Cancer Respiratory Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Cancer Respiratory Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Cancer Respiratory Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Owlstone Medical Revenue Growth Rate in Cancer Respiratory Biopsy Business (2020-2025)
Figure 51. Breath Diagnostics Revenue Growth Rate in Cancer Respiratory Biopsy Business (2020-2025)
Figure 52. Menssana Research Revenue Growth Rate in Cancer Respiratory Biopsy Business (2020-2025)
Figure 53. Sensigent Revenue Growth Rate in Cancer Respiratory Biopsy Business (2020-2025)
Figure 54. Alpha Szenszor Revenue Growth Rate in Cancer Respiratory Biopsy Business (2020-2025)
Figure 55. NanoScent Revenue Growth Rate in Cancer Respiratory Biopsy Business (2020-2025)
Figure 56. Spira Innovation Revenue Growth Rate in Cancer Respiratory Biopsy Business (2020-2025)
Figure 57. Syft Technologies Revenue Growth Rate in Cancer Respiratory Biopsy Business (2020-2025)
Figure 58. Breathe Biomedical Revenue Growth Rate in Cancer Respiratory Biopsy Business (2020-2025)
Figure 59. Vocxi Health Revenue Growth Rate in Cancer Respiratory Biopsy Business (2020-2025)
Figure 60. BREAX Biotech Revenue Growth Rate in Cancer Respiratory Biopsy Business (2020-2025)
Figure 61. ChromX Health Revenue Growth Rate in Cancer Respiratory Biopsy Business (2020-2025)
Figure 62. Sunvou Medical Revenue Growth Rate in Cancer Respiratory Biopsy Business (2020-2025)
Figure 63. MaiAoTech Revenue Growth Rate in Cancer Respiratory Biopsy Business (2020-2025)
Figure 64. Hanon Instruments Revenue Growth Rate in Cancer Respiratory Biopsy Business (2020-2025)
Figure 65. WIM Spirare Revenue Growth Rate in Cancer Respiratory Biopsy Business (2020-2025)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
